• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Define Ventures Appoints Bruce Broussard as Venture Partner

    10/22/24 9:00:00 AM ET
    $EVH
    $HIMS
    $HUM
    Other Consumer Services
    Consumer Discretionary
    Medical/Nursing Services
    Health Care
    Get the next $EVH alert in real time by email

    The former Fortune 50 CEO joins Define to further drive transformational change in healthcare at the earliest stages of innovation

    SAN FRANCISCO, Oct. 22, 2024 /PRNewswire/ -- Define Ventures, one of the largest venture capital firms focused on early-stage health tech companies, today announced that Bruce Broussard, former CEO and president of Humana (NYSE:HUM), has joined the firm as venture partner. Bruce will play a pivotal role at Define, leveraging his invaluable experience scaling companies and fostering innovation within private startups, mid-size companies, and the Fortune 50. He will partner closely with Define founders to scale their businesses and become category-defining companies. 

    Bruce is a seasoned healthcare executive and multi-time CEO, having held executive leadership positions across multiple corners of the ecosystem. Prior to joining Define, Bruce was president and CEO of Humana for over a dozen years. Under his leadership, Bruce led a strategic shift towards expanding the company into an integrated model with a growing care delivery focus. Bruce also held several roles at McKesson Specialty Health including CEO, CFO, President, and Chairman of the Board. He currently serves on the Humana Foundation Board, is Chair of the Board of Directors of the Trust for the National Mall, and is a board member for HP Inc. and One Call.

    "Bruce's extensive background and proven track record in leading healthcare organizations of all sizes makes him uniquely qualified to guide the next generation of health tech innovators," said Lynne Chou O'Keefe, founder and managing partner at Define Ventures. "Having had the privilege to closely partner with Bruce for the past decade, I am confident his decision to join our team will sharpen our investing theses, accelerate our partner companies' growth, strengthen our relationships with large healthcare organizations, and ultimately create a lasting impact on the broader health tech community."

    Bruce is joining a team that pulls the full weight of its network and expertise to play offense and drive results, including securing early customers, shaping commercial strategies, and building high-performing teams. As venture partner, Bruce will leverage his experience driving transformative change within complex healthcare organizations to help Define founders to navigate industry challenges and scale their innovations effectively. His perspective will also strengthen Define's close partnerships with its coalition of large health systems, health plans, employers, and life sciences companies, half of which are customers of Define partner companies.

    "What excites me the most about this role is the opportunity to work with brilliant, innovative entrepreneurs at the earliest stages of their journey," Broussard said. "Being able to see groundbreaking approaches from the start, and having the chance to shape products and help scale and bring them to market is truly invigorating. Ultimately, I chose to work with Define because I believe this firm is uniquely positioned and capable of driving real transformation in healthcare. The strong, trustworthy relationship we've built over the years has shown me that Define's vision aligns perfectly with my own. Together, I believe we can make significant strides in creating a healthcare system that's more efficient, more accessible, and more focused on keeping people healthy."

    Bruce's decision to join Define Ventures stems from his belief that the firm is uniquely positioned and capable of transforming healthcare. He has built a strong and trustworthy relationship with Define over the past several years, including first-hand experience in incubating and spinning out Cohere Health from Humana. This collaborative history underscores the alignment between Bruce's vision for healthcare innovation and Define's strategic approach.

    Define Ventures has $800 million in assets under management and partners with companies at the seed, series A and series B stages. The firm attracts leading health tech entrepreneurs with its high conviction approach, partnering with over two dozen companies including Hims & Hers (NYSE:HIMS) and Unite Us. This announcement follows Frank Williams, co-founder and former CEO of Evolent (NYSE:EVH) joining Define as venture partner earlier this year.

    To learn more about Define Ventures, visit www.definevc.com.

    About Define Ventures

    Define Ventures is one of the largest funds focused on early-stage health tech companies. With $800 AUM, we take a high conviction approach in partnering with companies at the earliest stages. We believe the future of healthcare will be defined who bring together a deep understanding of the healthcare ecosystem paired with a technology-driven mindset. Our team was built in this vision, bringing together founders and investors who built category-defining companies and delivered $23 billion in exit value, including Livongo (LVGO), Evolent (NYSE:EVH), and Hims & Hers (NYSE:HIMS).

    Cision View original content:https://www.prnewswire.com/news-releases/define-ventures-appoints-bruce-broussard-as-venture-partner-302282546.html

    SOURCE Define Ventures

    Get the next $EVH alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Q&A

    New
    • Who has joined Define Ventures as a venture partner, and what is his background?

      Bruce Broussard, the former CEO of Humana, has joined Define Ventures as a venture partner to drive transformative change in healthcare and support early-stage health tech companies.

    • What is Define Ventures' focus and how much capital do they manage?

      Define Ventures focuses on early-stage health tech companies and has $800 million in assets under management (AUM). They partner with companies typically at the seed, series A, and series B stages.

    • Why has Bruce Broussard chosen to work with Define Ventures?

      Broussard believes Define Ventures is uniquely positioned to drive real transformation in healthcare, based on his strong relationship with the firm and shared vision for healthcare innovation.

    • What role will Bruce Broussard play at Define Ventures?

      Broussard will leverage his extensive experience in healthcare to guide founders through challenges, helping them scale their innovations and strengthen partnerships with large healthcare organizations.

    • Which companies has Define Ventures partnered with, showcasing their investment strategy?

      Define Ventures has partnered with notable companies in the health tech space, including Hims & Hers and Unite Us, highlighting their investment strategy focused on impactful entrepreneurs.

    Recent Analyst Ratings for
    $EVH
    $HIMS
    $HUM

    CompanyDatePrice TargetRatingAnalyst
    Hims & Hers Health Inc.
    $HIMS
    6/23/2025Buy → Hold
    Needham
    Hims & Hers Health Inc.
    $HIMS
    6/4/2025$61.00 → $65.00Buy
    Needham
    Humana Inc.
    $HUM
    5/1/2025$315.00Mkt Perform → Outperform
    Raymond James
    Hims & Hers Health Inc.
    $HIMS
    4/29/2025$30.00Buy → Hold
    TD Cowen
    Hims & Hers Health Inc.
    $HIMS
    2/18/2025$42.00 → $60.00Overweight → Equal-Weight
    Morgan Stanley
    Hims & Hers Health Inc.
    $HIMS
    1/10/2025$24.00 → $25.00Neutral → Sell
    Citigroup
    Evolent Health Inc
    $EVH
    1/10/2025$15.00Buy
    Needham
    Hims & Hers Health Inc.
    $HIMS
    1/7/2025$35.00Buy
    BTIG Research
    More analyst ratings

    $EVH
    $HIMS
    $HUM
    SEC Filings

    See more
    • SEC Form 144 filed by Hims & Hers Health Inc.

      144 - Hims & Hers Health, Inc. (0001773751) (Subject)

      7/21/25 4:59:36 PM ET
      $HIMS
      Medical/Nursing Services
      Health Care
    • SEC Form SCHEDULE 13G filed by Evolent Health Inc

      SCHEDULE 13G - Evolent Health, Inc. (0001628908) (Subject)

      7/7/25 4:14:37 PM ET
      $EVH
      Other Consumer Services
      Consumer Discretionary
    • Amendment: SEC Form SCHEDULE 13G/A filed by Evolent Health Inc

      SCHEDULE 13G/A - Evolent Health, Inc. (0001628908) (Subject)

      7/7/25 11:58:37 AM ET
      $EVH
      Other Consumer Services
      Consumer Discretionary

    $EVH
    $HIMS
    $HUM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Commercial Officer Chi Michael exercised 15,850 shares at a strike of $5.22 and sold $890,792 worth of shares (15,850 units at $56.20) (SEC Form 4)

      4 - Hims & Hers Health, Inc. (0001773751) (Issuer)

      7/25/25 5:20:46 PM ET
      $HIMS
      Medical/Nursing Services
      Health Care
    • Chief Executive Officer Dudum Andrew exercised 125,335 shares at a strike of $2.43 and sold $6,208,637 worth of shares (125,335 units at $49.54) (SEC Form 4)

      4 - Hims & Hers Health, Inc. (0001773751) (Issuer)

      7/23/25 4:12:50 PM ET
      $HIMS
      Medical/Nursing Services
      Health Care
    • Chief Executive Officer Dudum Andrew sold $2,530,034 worth of shares (50,326 units at $50.27), decreasing direct ownership by 3% to 92,313 units (SEC Form 4)

      4 - Hims & Hers Health, Inc. (0001773751) (Issuer)

      7/18/25 4:29:16 PM ET
      $HIMS
      Medical/Nursing Services
      Health Care

    $EVH
    $HIMS
    $HUM
    Leadership Updates

    Live Leadership Updates

    See more
    • National Mall of Pickleball Returns for Third Year with Expanded Footprint and New, Central Location

      The National Mall of Pickleball will celebrate America's most accessible sport and the game that serves all in the heart of the National Mall this September The Trust for the National Mall, Humana (NYSE:HUM), and the Humana Foundation announced today that the highly-anticipated National Mall of Pickleball is returning to America's Front Yard, the National Mall, for a third year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250625316935/en/ From Friday, September 19 through Sunday, September 21, 2025, the general public can experience a weekend full of pickleball programming, activities, and community with captivating views o

      6/25/25 9:00:00 AM ET
      $HUM
      Medical Specialities
      Health Care
    • Humana Launches "Invite" Campaign to Inspire Active Aging Through Pickleball and Community Connection

      Humana Inc. (NYSE:HUM), a leading health and well-being company, is expanding its commitment to senior wellness with the launch of Invite, a new campaign designed to encourage older adults of all fitness levels to stay active, connected and engaged – starting with the fastest-growing sport in America: pickleball. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250618737488/en/As part of Humana's new "Invite" campaign, the health and wellness company debuted a television spot featuring senior pickleball athletes extending an open invitation to others to join the fun, stay social, and support their physical and mental well-being. A

      6/18/25 8:30:00 AM ET
      $HUM
      Medical Specialities
      Health Care
    • Hims & Hers Appoints AI Expert and Former President and CTO at Cruise as Chief Technology Officer

      Mo Elshenawy joins as the company doubles down on the role AI will play in the next generation of healthcare. Hims & Hers Health, Inc. (NYSE:HIMS), the leading health and wellness platform, today announced the appointment of Mo Elshenawy, a proven technology executive with deep expertise in artificial intelligence and large-scale infrastructure, as the company's new Chief Technology Officer. His appointment marks a key milestone as Hims & Hers accelerates its vision to build the next-generation healthcare platform, powered by AI and designed to deliver deeply personalized, accessible care at scale. This press release features multimedia. View the full release here: https://www.businesswire

      5/8/25 6:50:00 AM ET
      $HIMS
      Medical/Nursing Services
      Health Care

    $EVH
    $HIMS
    $HUM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • President & CEO Rechtin James A. bought $1,496,984 worth of Humana Common (6,530 units at $229.25) (SEC Form 4)

      4 - HUMANA INC (0000049071) (Issuer)

      5/16/25 4:48:13 PM ET
      $HUM
      Medical Specialities
      Health Care
    • Director Holder Diane bought $25,518 worth of shares (2,735 units at $9.33), increasing direct ownership by 4% to 70,584 units (SEC Form 4)

      4 - Evolent Health, Inc. (0001628908) (Issuer)

      3/10/25 8:20:54 AM ET
      $EVH
      Other Consumer Services
      Consumer Discretionary
    • PRESIDENT Mccarthy Daniel Joseph bought $99,470 worth of shares (11,040 units at $9.01), increasing direct ownership by 3% to 389,004 units (SEC Form 4)

      4 - Evolent Health, Inc. (0001628908) (Issuer)

      3/10/25 8:18:12 AM ET
      $EVH
      Other Consumer Services
      Consumer Discretionary

    $EVH
    $HIMS
    $HUM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Hims & Hers Health downgraded by Needham

      Needham downgraded Hims & Hers Health from Buy to Hold

      6/23/25 11:43:05 AM ET
      $HIMS
      Medical/Nursing Services
      Health Care
    • Needham reiterated coverage on Hims & Hers Health with a new price target

      Needham reiterated coverage of Hims & Hers Health with a rating of Buy and set a new price target of $65.00 from $61.00 previously

      6/4/25 7:59:55 AM ET
      $HIMS
      Medical/Nursing Services
      Health Care
    • Humana upgraded by Raymond James with a new price target

      Raymond James upgraded Humana from Mkt Perform to Outperform and set a new price target of $315.00

      5/1/25 7:42:13 AM ET
      $HUM
      Medical Specialities
      Health Care

    $EVH
    $HIMS
    $HUM
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Humana Accelerates Efforts to Eliminate Prior Authorization Requirements to Ensure a Faster, More Seamless Process

      New effort will expedite approvals, promote access to care, reduce administrative burdens, and enhance the patient experience Humana Inc., a leading health and well-being company, today announced accelerated efforts to approve care requests as quickly as possible and reduce the administrative burden for physicians associated with prior authorization. These actions will reduce the number of prior authorization requirements and make the process faster and more seamless, while preserving the system of checks and balances that protects patient safety by ensuring the most high-cost, high-risk treatments are reviewed and approved before care is delivered. Today's announcement builds upon the

      7/22/25 6:00:00 AM ET
      $HUM
      Medical Specialities
      Health Care
    • Humana Simplifies Access to Coverage and Care Information

      First-of-its-kind MyChart integration gives Medicare Advantage members one-stop access to health plan and clinical information Humana Inc. (NYSE:HUM) announced today its latest collaboration with healthcare software company Epic, becoming the first health insurer to integrate health plan information directly into the MyChart accounts patients may already use with their healthcare providers. This enables Humana Medicare Advantage members to access their insurance details – such as vital coverage information, benefits, contacts and other resources – in the same place where they manage the rest of their care. "We are dedicated to making our members' healthcare experience as smooth and ef

      7/15/25 9:34:00 AM ET
      $HUM
      Medical Specialities
      Health Care
    • Hims & Hers to Announce Second Quarter 2025 Financial Results on August 4, 2025

      Hims & Hers Health, Inc. (("Hims &, Hers", NYSE:HIMS), the leading health and wellness platform, today announced that it will report second quarter 2025 financial results after the market closes on Monday, August 4, 2025. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day. The conference call can be accessed by dialing (888) 510-2630 for U.S. participants and (646) 960-0137 for international participants, referencing conference ID 1704296. A live audio webcast will be available at https://investors.hims.com and will be archived for one year. Upcoming Conference Participation Hims & Hers also announced that members of the company's manageme

      7/14/25 4:05:00 PM ET
      $HIMS
      Medical/Nursing Services
      Health Care

    $EVH
    $HIMS
    $HUM
    Financials

    Live finance-specific insights

    See more
    • Hims & Hers to Announce Second Quarter 2025 Financial Results on August 4, 2025

      Hims & Hers Health, Inc. (("Hims &, Hers", NYSE:HIMS), the leading health and wellness platform, today announced that it will report second quarter 2025 financial results after the market closes on Monday, August 4, 2025. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day. The conference call can be accessed by dialing (888) 510-2630 for U.S. participants and (646) 960-0137 for international participants, referencing conference ID 1704296. A live audio webcast will be available at https://investors.hims.com and will be archived for one year. Upcoming Conference Participation Hims & Hers also announced that members of the company's manageme

      7/14/25 4:05:00 PM ET
      $HIMS
      Medical/Nursing Services
      Health Care
    • Evolent To Release Second Quarter 2025 Financial Results on Thursday, August 7, 2025

      Company to Participate in Upcoming Conferences WASHINGTON, July 14, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE:EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced it will release its second quarter 2025 financial results on Thursday, August 7, 2025, after market close, with a conference call to follow at 5 p.m. ET. Shareholders and interested participants may listen to a live broadcast of the conference call found on Evolent's investor relations website, https://ir.evolent.com. Analysts interested in asking questions during the live call should dial 855.940.9467, or 412.317.6034 for international callers, and reference the "Evo

      7/14/25 8:00:00 AM ET
      $EVH
      Other Consumer Services
      Consumer Discretionary
    • Humana Inc. to Release Second Quarter 2025 Results on July 30, 2025

      Humana will release its 2Q25 financial results, as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on July 30, 2025. The company will host a live question-and-answer session at 8:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2025. A webcast of the 2Q25 earnings call may be accessed via Humana's Investor Relations page at https://humana.gcs-web.com/. If you anticipate asking a question during the question-and-answer session, please register in advance using this link, https://register-conf.media-server.com/register/BIb5c00e1d1dc14cd7ad2b375d4f1cde21. Upon registration, telephone participants w

      7/9/25 4:15:00 PM ET
      $HUM
      Medical Specialities
      Health Care

    $EVH
    $HIMS
    $HUM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Hims & Hers Health Inc.

      SC 13G/A - Hims & Hers Health, Inc. (0001773751) (Subject)

      11/12/24 3:52:47 PM ET
      $HIMS
      Medical/Nursing Services
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Evolent Health Inc

      SC 13G/A - Evolent Health, Inc. (0001628908) (Subject)

      11/12/24 9:55:15 AM ET
      $EVH
      Other Consumer Services
      Consumer Discretionary
    • Amendment: SEC Form SC 13G/A filed by Hims & Hers Health Inc.

      SC 13G/A - Hims & Hers Health, Inc. (0001773751) (Subject)

      11/4/24 1:33:02 PM ET
      $HIMS
      Medical/Nursing Services
      Health Care